Renal Cancers Completed Phase 2 Trials for Denileukin diftitox (DB00004)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00082914Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney CancerTreatment